Clinical Considerations for Use of SGLT2 Inhibitor Therapy in Patients with Heart Failure and Reduced Ejection Fraction: A Review

Jhalani, N. B. (2022). Clinical Considerations for Use of SGLT2 Inhibitor Therapy in Patients with Heart Failure and Reduced Ejection Fraction: A Review. Advances in Therapy, 39(8), 3472–3487. https://doi.org/10.1007/s12325-022-02169-3
Authors:
Nisha B Jhalani
Affiliated Authors:
Nisha B Jhalani
Columbia Affiliation:
Subjects:
Diabetes Mellitus, Type 2 (MeSH)
Heart Failure (MeSH)
Sodium-Glucose Transporter 2 Inhibitors (MeSH)
Author Keywords:
cardiovascular
heart failure
sodium–glucose cotransporter 2 inhibitors
type 2 diabetes
elink
Publication Type:
Article
Unique ID:
10.1007/s12325-022-02169-3
PMID:
35699903
DOI:
10.1007/s12325-022-02169-3
Journal:
Advances in Therapy
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: